Journey Medical Corporation Common Stock (DERM)
Journey Medical Corporation (DERM) is a dermatology-focused biopharmaceutical company that develops and commercializes dermatology products. The company focuses on acquiring, developing, and marketing prescription and over-the-counter dermatology treatments, aiming to address unmet needs in skin health and dermatological care.
Company News
EmergingGrowth.com announced the schedule for its 85th conference featuring presentations from multiple public companies across various sectors on August 20-21, 2025, providing insights into emerging growth companies.
Neurocrine (NBIX) delivered earnings and revenue surprises of -59.62% and 0.60%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
The Dow Jones index closed higher by over 475 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Retractable Technologies The Trade: Retractable Technologies, Inc. (NYSE: RVP) President and CEO Thomas J Shaw acquired a total of 5,096 shares an average price of $1.18. To ...
